MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.
| Image |  |
|---|---|
| Description | scientific article published on 8 February 2012 |
| Author/s |
author: Giorgio Zauli Rebecca Voltan Alessia Norcio Paola Secchiero Claudio Celeghini Elisabetta Melloni |
| Publication date | February 8, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |